Medicine Quality Alert: Class II Medicine Recall of Medopress (Methyldopa 250mg) Tablets Batch No. 221137, 230051, 230093, and 230165
The Pharmacy and Poisons Board has mandated Cosmos Ltd to initiate an urgent recall of medopress (methyldopa 250mg) tablets Batch no. 221137, 230051, 230093, and 230165 manufactured by Cosmos Ltd, Kenya.
From: Pharmacy and Poisons Board
Date initiated: 3rd April 2025
Recall Reference Number: REC/2025/011
Recall Classification: Class II
Recall Level: Retail/Facility level
Manufacturer: Cosmos Ltd, Kenya
Product name: Medopress
Active Pharmaceutical Ingredient: Methyldopa 250mg
Affected counties: All
Affected Batch
Batch Number | Date of Manufacture | Date of expiry | Pack Size |
230093 | 11/2023 | 10/2026 | 10×10 |
230051 | 05/2023 | 04/2026 | 10×10 |
221137 | 03/2023 | 02/2026 | 10×10 |
230165. | 03/2023 | 02/2026 | 10×10 |
Brief description of the problem
The product is being recalled due to color change of the tablets.
Action for healthcare professionals
Quarantine all remaining stock and stop further distribution, sale, issuing or use of the above batches immediately. Await contact from Cosmos Ltd to arrange the return.
Action for patients and caregivers
No further action is required by patients as this is a Retail/hospital Pharmacy and Wholesaler/Distributor level recall. You are advised to talk to your healthcare professional if you have the above batches of medopress (methyldopa 250mg) tablets
Further Information
For inquiries about consignments of the impacted batch, please contact Cosmos Ltd at: lina.lakhani@cosmos-pharm.com, info@cosmos-pharm.com or by Telephone at: + 254 (0) 709 864 000, + 254 (0) 722 333 834, + 254 (0) 733 666 834
You are advised to promptly report any case(s) of adverse events and suspected substandard and falsified products to the nearest healthcare facility or through the following channels:
- https://pv.pharmacyboardkenya.org/users/mpublic
- USSD code at *271#
- Email pv@ppb.go.ke or pms@ppb.go.ke
- Telephone No. 0795743049
- Mobile application: mPvERS both Android and iOS
For any further enquiries and feedback on the product recall, contact the post-marketing surveillance unit at the Pharmacy and Poisons Board via email at pms@ppb.go.ke
Download document
Medicine Quality Alert: Class II Medicine Recall of Medopress (Methyldopa 250mg) Tablets Batch No. 221137, 230051, 230093, and 230165